Carmelo Laface
Impact in
-
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Cancer Treatment and Pharmacology
Papers in
- Oncology 13
- Cancer Immunotherapy and Biomarkers 8
- HER2/EGFR in Cancer Research 3
- Pancreatic and Hepatic Oncology Research 3
-
- Advanced Breast Cancer Therapies 5
- Co-authors
- Mariarita Laforgia (9 shared papers)Cosmo Damiano Gadaleta (9 shared papers)Girolamo Ranieri (8 shared papers)Francesca Ambrogio (16 shared papers)Palma Fedele (9 shared papers)Michele Ammendola (9 shared papers)Caterina Foti (10 shared papers)P. De Santis (6 shared papers)
In The Last Decade
Carmelo Laface
31 papers receiving 308 citations
Peers
Comparison fields: 5 of 54
- Hepatology 35
- Oncology 107
- Pulmonary and Respiratory Medicine 74
- Immunology 42
- Pathology and Forensic Medicine 26
Countries citing papers authored by Carmelo Laface
This map shows the geographic impact of Carmelo Laface's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmelo Laface with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmelo Laface more than expected).
Fields of papers citing papers by Carmelo Laface
This network shows the impact of papers produced by Carmelo Laface. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmelo Laface. The network helps show where Carmelo Laface may publish in the future.
Co-authors
The 25 scholars most cited alongside Carmelo Laface, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 42 | |
| 2 | 2021 | 37 | |
| 3 | 2021 | 25 | |
| 4 | 2023 | 25 | |
| 5 | 2021 | 17 | |
| 6 | 2022 | 16 | |
| 7 | 2023 | 14 | |
| 8 | 2020 | 13 | |
| 9 | 2023 | 13 | |
| 10 | 2023 | 13 | |
| 11 | 2021 | 12 | |
| 12 | 2020 | 9 | |
| 13 | 2020 | 9 | |
| 14 | 2024 | 8 | |
| 15 | 2022 | 8 | |
| 16 | 2024 | 6 | |
| 17 | 2023 | 6 | |
| 18 | 2020 | 6 | |
| 19 | 2022 | 5 | |
| 20 | 2023 | 4 |
About Carmelo Laface
Carmelo Laface is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Immunology and Epidemiology, having authored 35 papers that have together received 309 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Advanced Breast Cancer Therapies (5 papers), Mast cells and histamine (4 papers), HER2/EGFR in Cancer Research (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Immunotherapy and Immune Responses (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Breast Cancer Treatment Studies (2 papers). The work is most often cited by research in Hepatology (35 citations), Oncology (107 citations), Pulmonary and Respiratory Medicine (74 citations), Immunology (42 citations) and Pathology and Forensic Medicine (26 citations). Carmelo Laface has collaborated with scholars based in Italy, Türkiye and Albania. Frequent co-authors include Mariarita Laforgia, Cosmo Damiano Gadaleta, Girolamo Ranieri, Francesca Ambrogio, Palma Fedele, Michele Ammendola, Caterina Foti, P. De Santis, Anna Santoro and Patrizia Nardulli. Their work appears in journals such as Cancers, Journal of Clinical Medicine, Cells, International Journal of Molecular Sciences and Vaccines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.